SKI Market

A+| A| A-|

Indian Indices

Sensex

74,207.24 -2,496.89
( -3.26%)

Global Indices

Nasdaq

46,043.89 -202.27
(-0.44%)

Dow Jones

6,628.50 -17.20
(-0.26%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

10,057.93 -247.36
(-2.40%)

Forex

USD-INR

92.39 0.06
(0.06%)

EUR-INR

106.38 0.46
(0.44%)

GBP-INR

123.15 0.52
(0.42%)

JPY-INR

0.58 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astrazeneca Pharma India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

506820

INE203A01020

319.6

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ASTRAZEN

100.4

20886.13

EPS(TTM)

Face Value()

Div & Yield %

83.21

0.38

Back

Swarna Securities standalone net profit rises 9.09% in the September 2025 quarter

Nov 01,2025

Net profit of Swarna Securities rose 9.09% to Rs 0.24 crore in the quarter ended September 2025 as against Rs 0.22 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

74,207.24 -2,496.89 ( -3.26%)

46,043.89 -202.27 (-0.44%)

6,628.50 -17.20 (-0.26%)

53,297.18 -1,942.22 (-3.52%)

10,057.93 -247.36 (-2.40%)

92.39 0.06 (0.06%)

106.38 0.46 (0.44%)

123.15 0.52 (0.42%)

0.58 0.00 (0.14%)